Insourcing or outsourcing in clinical trials is a late-breaking topic. Despite other branches of trade such as the automotive industry where large companies are experiencing a comeback of insourcing, the conduct of clinical trials are mostly outsourced to contract research organizations (CROs).
Deciding on when to outsource clinical services and to who is likely to be a decision on a case-by-case basis, depending on the project, capabilities and resources needed. The benefit of outsourcing lies with potential reduced costs, strengthened performance and flexibility. Even though there may be clear advantages to outsourcing from a financial point of view, the industry is not always willing to take risks due to a lack of trust.
Download this white paper and discover the benefits and challenges of both insourcing and outsourcing and what to take into consideration when outsourcing your clinical trial to a CRO.